Butterfly Network, Inc.

Butterfly Network, Inc. (NYSE: BFLY) is a medical technology company that entered public markets through a merger with Longview Acquisition Corp., a blank-check company sponsored by Glenview Capital Management. Longview filed its S-1 registration statement in May 2020 and completed its IPO that year, with the vehicle targeting the healthcare and life sciences sector. The de-SPAC transaction closed in February 2021, combining Butterfly Network's chip-based, handheld whole-body ultrasound technology platform with Longview's capital base. The combined company trades on the New York Stock Exchange under the BFLY ticker and remains an active publicly traded medical device issuer. Sign up at SpacDesk for the complete filing history, shareholder data, and deal analytics on BFLY and hundreds of other SPAC transactions.